Exosomes are small extracellular vesicles released by various cells into the extracellular space. They contain proteins, lipids, and nucleic acids, playing a role in intercellular communication.
The global Exosome Detection and Diagnosis market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淓xosome Detection and Diagnosis Industry Forecast鈥� looks at past sales and reviews total world Exosome Detection and Diagnosis sales in 2023, providing a comprehensive analysis by region and market sector of projected Exosome Detection and Diagnosis sales for 2024 through 2030. With Exosome Detection and Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Detection and Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Exosome Detection and Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Exosome Detection and Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Exosome Detection and Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Detection and Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Detection and Diagnosis.
United States market for Exosome Detection and Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Exosome Detection and Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Exosome Detection and Diagnosis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Exosome Detection and Diagnosis players cover Thermo Fisher Scientific, Bio-Techne, System Biosciences, QIAGEN and Lonza, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Detection and Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by type
Kits & Reagents
Instruments
Services
Segmentation by application
Cancers
Neurodegenerative Diseases
Cardiovascular Diseases
Infectious Diseases
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Bio-Techne
System Biosciences
QIAGEN
Lonza
NX Pharmagen
NanoSomiX
Miltenyi Biotech
Norgen Biotek
AMSBio
Aethlon Medical
Anjarium Biosciences
Ciloa
InnovaPrep
Creative Medical Technologies
ILIAS Biologics
Unchained Labs
Rion
Cell Guidance System
INOVIQ
Danaher
Exopharm
Everzom
RoosterBio
Creative Biolabs
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exosome Detection and Diagnosis Market Size 2019-2030
2.1.2 Exosome Detection and Diagnosis Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Exosome Detection and Diagnosis Segment by Type
2.2.1 Kits & Reagents
2.2.2 Instruments
2.2.3 Services
2.3 Exosome Detection and Diagnosis Market Size by Type
2.3.1 Exosome Detection and Diagnosis Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Detection and Diagnosis Market Size Market Share by Type (2019-2024)
2.4 Exosome Detection and Diagnosis Segment by Application
2.4.1 Cancers
2.4.2 Neurodegenerative Diseases
2.4.3 Cardiovascular Diseases
2.4.4 Infectious Diseases
2.4.5 Other
2.5 Exosome Detection and Diagnosis Market Size by Application
2.5.1 Exosome Detection and Diagnosis Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Detection and Diagnosis Market Size Market Share by Application (2019-2024)
3 Exosome Detection and Diagnosis Market Size by Player
3.1 Exosome Detection and Diagnosis Market Size Market Share by Players
3.1.1 Global Exosome Detection and Diagnosis Revenue by Players (2019-2024)
3.1.2 Global Exosome Detection and Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Detection and Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exosome Detection and Diagnosis by Regions
4.1 Exosome Detection and Diagnosis Market Size by Regions (2019-2024)
4.2 Americas Exosome Detection and Diagnosis Market Size Growth (2019-2024)
4.3 APAC Exosome Detection and Diagnosis Market Size Growth (2019-2024)
4.4 Europe Exosome Detection and Diagnosis Market Size Growth (2019-2024)
4.5 Middle East & Africa Exosome Detection and Diagnosis Market Size Growth (2019-2024)
5 Americas
5.1 Americas Exosome Detection and Diagnosis Market Size by Country (2019-2024)
5.2 Americas Exosome Detection and Diagnosis Market Size by Type (2019-2024)
5.3 Americas Exosome Detection and Diagnosis Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Detection and Diagnosis Market Size by Region (2019-2024)
6.2 APAC Exosome Detection and Diagnosis Market Size by Type (2019-2024)
6.3 APAC Exosome Detection and Diagnosis Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exosome Detection and Diagnosis by Country (2019-2024)
7.2 Europe Exosome Detection and Diagnosis Market Size by Type (2019-2024)
7.3 Europe Exosome Detection and Diagnosis Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exosome Detection and Diagnosis by Region (2019-2024)
8.2 Middle East & Africa Exosome Detection and Diagnosis Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Detection and Diagnosis Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Exosome Detection and Diagnosis Market Forecast
10.1 Global Exosome Detection and Diagnosis Forecast by Regions (2025-2030)
10.1.1 Global Exosome Detection and Diagnosis Forecast by Regions (2025-2030)
10.1.2 Americas Exosome Detection and Diagnosis Forecast
10.1.3 APAC Exosome Detection and Diagnosis Forecast
10.1.4 Europe Exosome Detection and Diagnosis Forecast
10.1.5 Middle East & Africa Exosome Detection and Diagnosis Forecast
10.2 Americas Exosome Detection and Diagnosis Forecast by Country (2025-2030)
10.2.1 United States Exosome Detection and Diagnosis Market Forecast
10.2.2 Canada Exosome Detection and Diagnosis Market Forecast
10.2.3 Mexico Exosome Detection and Diagnosis Market Forecast
10.2.4 Brazil Exosome Detection and Diagnosis Market Forecast
10.3 APAC Exosome Detection and Diagnosis Forecast by Region (2025-2030)
10.3.1 China Exosome Detection and Diagnosis Market Forecast
10.3.2 Japan Exosome Detection and Diagnosis Market Forecast
10.3.3 Korea Exosome Detection and Diagnosis Market Forecast
10.3.4 Southeast Asia Exosome Detection and Diagnosis Market Forecast
10.3.5 India Exosome Detection and Diagnosis Market Forecast
10.3.6 Australia Exosome Detection and Diagnosis Market Forecast
10.4 Europe Exosome Detection and Diagnosis Forecast by Country (2025-2030)
10.4.1 Germany Exosome Detection and Diagnosis Market Forecast
10.4.2 France Exosome Detection and Diagnosis Market Forecast
10.4.3 UK Exosome Detection and Diagnosis Market Forecast
10.4.4 Italy Exosome Detection and Diagnosis Market Forecast
10.4.5 Russia Exosome Detection and Diagnosis Market Forecast
10.5 Middle East & Africa Exosome Detection and Diagnosis Forecast by Region (2025-2030)
10.5.1 Egypt Exosome Detection and Diagnosis Market Forecast
10.5.2 South Africa Exosome Detection and Diagnosis Market Forecast
10.5.3 Israel Exosome Detection and Diagnosis Market Forecast
10.5.4 Turkey Exosome Detection and Diagnosis Market Forecast
10.5.5 GCC Countries Exosome Detection and Diagnosis Market Forecast
10.6 Global Exosome Detection and Diagnosis Forecast by Type (2025-2030)
10.7 Global Exosome Detection and Diagnosis Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Exosome Detection and Diagnosis Product Offered
11.1.3 Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Exosome Detection and Diagnosis Product Offered
11.2.3 Bio-Techne Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 System Biosciences
11.3.1 System Biosciences Company Information
11.3.2 System Biosciences Exosome Detection and Diagnosis Product Offered
11.3.3 System Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 System Biosciences Main Business Overview
11.3.5 System Biosciences Latest Developments
11.4 QIAGEN
11.4.1 QIAGEN Company Information
11.4.2 QIAGEN Exosome Detection and Diagnosis Product Offered
11.4.3 QIAGEN Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 QIAGEN Main Business Overview
11.4.5 QIAGEN Latest Developments
11.5 Lonza
11.5.1 Lonza Company Information
11.5.2 Lonza Exosome Detection and Diagnosis Product Offered
11.5.3 Lonza Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Lonza Main Business Overview
11.5.5 Lonza Latest Developments
11.6 NX Pharmagen
11.6.1 NX Pharmagen Company Information
11.6.2 NX Pharmagen Exosome Detection and Diagnosis Product Offered
11.6.3 NX Pharmagen Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 NX Pharmagen Main Business Overview
11.6.5 NX Pharmagen Latest Developments
11.7 NanoSomiX
11.7.1 NanoSomiX Company Information
11.7.2 NanoSomiX Exosome Detection and Diagnosis Product Offered
11.7.3 NanoSomiX Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 NanoSomiX Main Business Overview
11.7.5 NanoSomiX Latest Developments
11.8 Miltenyi Biotech
11.8.1 Miltenyi Biotech Company Information
11.8.2 Miltenyi Biotech Exosome Detection and Diagnosis Product Offered
11.8.3 Miltenyi Biotech Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Miltenyi Biotech Main Business Overview
11.8.5 Miltenyi Biotech Latest Developments
11.9 Norgen Biotek
11.9.1 Norgen Biotek Company Information
11.9.2 Norgen Biotek Exosome Detection and Diagnosis Product Offered
11.9.3 Norgen Biotek Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Norgen Biotek Main Business Overview
11.9.5 Norgen Biotek Latest Developments
11.10 AMSBio
11.10.1 AMSBio Company Information
11.10.2 AMSBio Exosome Detection and Diagnosis Product Offered
11.10.3 AMSBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AMSBio Main Business Overview
11.10.5 AMSBio Latest Developments
11.11 Aethlon Medical
11.11.1 Aethlon Medical Company Information
11.11.2 Aethlon Medical Exosome Detection and Diagnosis Product Offered
11.11.3 Aethlon Medical Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Aethlon Medical Main Business Overview
11.11.5 Aethlon Medical Latest Developments
11.12 Anjarium Biosciences
11.12.1 Anjarium Biosciences Company Information
11.12.2 Anjarium Biosciences Exosome Detection and Diagnosis Product Offered
11.12.3 Anjarium Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Anjarium Biosciences Main Business Overview
11.12.5 Anjarium Biosciences Latest Developments
11.13 Ciloa
11.13.1 Ciloa Company Information
11.13.2 Ciloa Exosome Detection and Diagnosis Product Offered
11.13.3 Ciloa Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Ciloa Main Business Overview
11.13.5 Ciloa Latest Developments
11.14 InnovaPrep
11.14.1 InnovaPrep Company Information
11.14.2 InnovaPrep Exosome Detection and Diagnosis Product Offered
11.14.3 InnovaPrep Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 InnovaPrep Main Business Overview
11.14.5 InnovaPrep Latest Developments
11.15 Creative Medical Technologies
11.15.1 Creative Medical Technologies Company Information
11.15.2 Creative Medical Technologies Exosome Detection and Diagnosis Product Offered
11.15.3 Creative Medical Technologies Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Creative Medical Technologies Main Business Overview
11.15.5 Creative Medical Technologies Latest Developments
11.16 ILIAS Biologics
11.16.1 ILIAS Biologics Company Information
11.16.2 ILIAS Biologics Exosome Detection and Diagnosis Product Offered
11.16.3 ILIAS Biologics Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 ILIAS Biologics Main Business Overview
11.16.5 ILIAS Biologics Latest Developments
11.17 Unchained Labs
11.17.1 Unchained Labs Company Information
11.17.2 Unchained Labs Exosome Detection and Diagnosis Product Offered
11.17.3 Unchained Labs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Unchained Labs Main Business Overview
11.17.5 Unchained Labs Latest Developments
11.18 Rion
11.18.1 Rion Company Information
11.18.2 Rion Exosome Detection and Diagnosis Product Offered
11.18.3 Rion Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Rion Main Business Overview
11.18.5 Rion Latest Developments
11.19 Cell Guidance System
11.19.1 Cell Guidance System Company Information
11.19.2 Cell Guidance System Exosome Detection and Diagnosis Product Offered
11.19.3 Cell Guidance System Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Cell Guidance System Main Business Overview
11.19.5 Cell Guidance System Latest Developments
11.20 INOVIQ
11.20.1 INOVIQ Company Information
11.20.2 INOVIQ Exosome Detection and Diagnosis Product Offered
11.20.3 INOVIQ Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 INOVIQ Main Business Overview
11.20.5 INOVIQ Latest Developments
11.21 Danaher
11.21.1 Danaher Company Information
11.21.2 Danaher Exosome Detection and Diagnosis Product Offered
11.21.3 Danaher Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Danaher Main Business Overview
11.21.5 Danaher Latest Developments
11.22 Exopharm
11.22.1 Exopharm Company Information
11.22.2 Exopharm Exosome Detection and Diagnosis Product Offered
11.22.3 Exopharm Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Exopharm Main Business Overview
11.22.5 Exopharm Latest Developments
11.23 Everzom
11.23.1 Everzom Company Information
11.23.2 Everzom Exosome Detection and Diagnosis Product Offered
11.23.3 Everzom Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 Everzom Main Business Overview
11.23.5 Everzom Latest Developments
11.24 RoosterBio
11.24.1 RoosterBio Company Information
11.24.2 RoosterBio Exosome Detection and Diagnosis Product Offered
11.24.3 RoosterBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 RoosterBio Main Business Overview
11.24.5 RoosterBio Latest Developments
11.25 Creative Biolabs
11.25.1 Creative Biolabs Company Information
11.25.2 Creative Biolabs Exosome Detection and Diagnosis Product Offered
11.25.3 Creative Biolabs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Creative Biolabs Main Business Overview
11.25.5 Creative Biolabs Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
